558 related articles for article (PubMed ID: 17453398)
1. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
2. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
3. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
[TBL] [Abstract][Full Text] [Related]
4. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
Sell S; Phillips O; Handel M
Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
[TBL] [Abstract][Full Text] [Related]
5. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
7. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
[TBL] [Abstract][Full Text] [Related]
8. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
10. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
11. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.
Pakos EE; Ioannidis JP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):888-95. PubMed ID: 15465207
[TBL] [Abstract][Full Text] [Related]
14. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
Vogt L; de Zeeuw D; Woittiez AJ; Navis G
Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
[TBL] [Abstract][Full Text] [Related]
16. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
17. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam.
van der Heide HJ; Spruit M; Slappendel R; Klooster N; van Limbeek J
Acta Orthop Belg; 2004 Jun; 70(3):240-6. PubMed ID: 15287403
[TBL] [Abstract][Full Text] [Related]
19. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
[TBL] [Abstract][Full Text] [Related]
20. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.
van der Heide HJ; Koorevaar RT; Schreurs BW; van Kampen A; Lemmens A
J Arthroplasty; 1999 Oct; 14(7):796-9. PubMed ID: 10537252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
